Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Coetzee

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Neurology|April 21, 2025
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical TrialsLudwig Kappos, Sean Yiu, Frank Dahlke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2022
Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC)Dejan Jakimovski, Katelyn S Kavak, Karen Zakalik, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Proteomic mapping provides powerful insights into functional myelin biologyChristopher M Taylor, Cecilia B Marta, Robert J Claycomb, et al.
Neuron|December 3, 2014
Medicines for the mind: policy-based "pull" incentives for creating breakthrough CNS drugsDennis W Choi, Robert Armitage, Linda S Brady, et al.
Nutrition Today|June 11, 2025
Best Practices for Communicating Nutrition and Brain Health ScienceLauren B Roberson, Marie E Latulippe, Sarah D Ohlhorst, et al.
The Lancet. Neurology|November 21, 2022
Multiple sclerosis progression: time for a new mechanism-driven frameworkTanja Kuhlmann, Marcello Moccia, Timothy Coetzee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2024
The refined Pathways to Cures Research Roadmap for multiple sclerosis curesBruce F Bebo, Brenda L Banwell, Caroline C Whitacre, et al.
Nature Reviews. Neurology|January 23, 2021
Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposalFernando Dangond, Alexis Donnelly, Reinhard Hohlfeld, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2022
Pathways to cures for multiple sclerosis: A research roadmapBruce F Bebo, Mark Allegretta, Douglas Landsman, et al.
Neurology. Clinical Practice|June 26, 2026
Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and OpportunityAndrew J Solomon, Magd Zakaria, Deanna R Saylor, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Neurology|April 21, 2025
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical TrialsLudwig Kappos, Sean Yiu, Frank Dahlke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2022
Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC)Dejan Jakimovski, Katelyn S Kavak, Karen Zakalik, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Proteomic mapping provides powerful insights into functional myelin biologyChristopher M Taylor, Cecilia B Marta, Robert J Claycomb, et al.
Neuron|December 3, 2014
Medicines for the mind: policy-based "pull" incentives for creating breakthrough CNS drugsDennis W Choi, Robert Armitage, Linda S Brady, et al.
Nutrition Today|June 11, 2025
Best Practices for Communicating Nutrition and Brain Health ScienceLauren B Roberson, Marie E Latulippe, Sarah D Ohlhorst, et al.
The Lancet. Neurology|November 21, 2022
Multiple sclerosis progression: time for a new mechanism-driven frameworkTanja Kuhlmann, Marcello Moccia, Timothy Coetzee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2024
The refined Pathways to Cures Research Roadmap for multiple sclerosis curesBruce F Bebo, Brenda L Banwell, Caroline C Whitacre, et al.
Nature Reviews. Neurology|January 23, 2021
Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposalFernando Dangond, Alexis Donnelly, Reinhard Hohlfeld, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2022
Pathways to cures for multiple sclerosis: A research roadmapBruce F Bebo, Mark Allegretta, Douglas Landsman, et al.
Neurology. Clinical Practice|June 26, 2026
Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and OpportunityAndrew J Solomon, Magd Zakaria, Deanna R Saylor, et al.
Pageof 4